Compare CRVS & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVS | BLBD |
|---|---|---|
| Founded | 2014 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2016 | 2013 |
| Metric | CRVS | BLBD |
|---|---|---|
| Price | $14.09 | $56.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $28.20 | ★ $67.17 |
| AVG Volume (30 Days) | ★ 1.1M | 323.8K |
| Earning Date | 03-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.04 | 22.78 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $1,480,099,000.00 |
| Revenue This Year | N/A | $6.14 |
| Revenue Next Year | N/A | $6.56 |
| P/E Ratio | ★ N/A | $61.08 |
| Revenue Growth | N/A | ★ 9.87 |
| 52 Week Low | $2.54 | $30.15 |
| 52 Week High | $26.95 | $62.90 |
| Indicator | CRVS | BLBD |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 53.94 |
| Support Level | $6.65 | $56.19 |
| Resistance Level | $18.73 | $59.42 |
| Average True Range (ATR) | 0.95 | 1.70 |
| MACD | -0.21 | 0.18 |
| Stochastic Oscillator | 27.18 | 79.93 |
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.